Bilberry
OtherFruit beverage with bilberry and fermented oatmeal
NCT Number: NCT03159065
Consumption of polyphenol-rich fruits and vegetables may improve the postprandial glucose and insulin responses and hence promote well-being. It has previously been observed that consumption of a bilberry drink decreases the postprandial insulin demand. In the present study, the impact of probiotic fruit beverages with different polyphenol profiles on the postprandial levels of glucose and insulin, were investigated.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Fruit beverage with bilberry and fermented oatmeal
Fruit beverage with blackcurrant and fermented oatmeal
Fruit beverage with mango and fermented oatmeal
Fruit beverage with beetroot and fermented oatmeal
Fruit beverage with rose hip and fermented oatmeal
A reference glucose drink
Time frame: Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product
The postprandial incremental area under the curve for serum insulin
Time frame: Incremental area under the curve for serum glucose from 0 min up to 120 min following the ingestion of the study product
The postprandial incremental area under the curve for serum glucose
Lund University
Other
Early Postprandial Efficacy of Probiotic Fruit Beverages on Glucose Tolerance and Insulin Resistance in Healthy Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836495
Energy Expenditure, Glucose Metabolism Disorders
Beirut, Lebanon
View Trial DetailsNCT04430439
Behavior, Behavioral Symptoms
Irvine, California, United States
View Trial DetailsNCT05783752
Glucose Metabolism Disorders, Hyperglycemia
San Diego, California, United States
View Trial DetailsNCT03624569
Bacteremia, Cardiovascular Diseases
Columbus, Ohio, United States
View Trial Details